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Association of Renal Manifestations with Serum Uric Acid in 
Korean Adults with Normal Uric Acid Levels
Several studies have reported that hyperuricemia is associated with the development of 
hypertension and cardiovascular disease. Increasing evidences also suggest that 
hyperuricemia may have a pathogenic role in the progression of renal disease. 
Paradoxically, uric acid is also widely accepted to have antioxidant activity in experimental 
studies. We aimed to investigate the association between glomerular filtration rate (GFR) 
and uric acid in healthy individuals with a normal serum level of uric acid. We examined 
renal function determined by GFR and uric acid in 3,376 subjects (1,896 men; 1,480 
women; aged 20-80 yr) who underwent medical examinations at Gangnam Severance 
Hospital from November 2006 to June 2007. Determinants for renal function and uric acid 
levels were also investigated. In both men and women, GFR was negatively correlated with 
systolic and diastolic blood pressures, fasting plasma glucose, total cholesterol, uric acid, 
log transformed C reactive protein, and log transformed triglycerides. In multivariate 
regression analysis, total uric acid was found to be an independent factor associated with 
estimated GFR in both men and women. This result suggests that uric acid appears to 
contribute to renal impairment in subjects with normal serum level of uric acid. 
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INTRODUCTION
Several studies have reported that hyperuricemia is associated 
with the development of hypertension and cardiovascular dis-
ease (1-3). In addition, epidemiological studies have shown an 
association between a high level of serum uric acid and increased 
vascular events and mortality in patients with hypertension (4). 
 More evidences also show that hyperuricemia may have a 
pathogenetic role in the progression of renal disease (5). Iseki et 
al. (6) showed that an elevated serum uric acid level correlated 
with the development of renal insufficiency in individuals with 
normal kidney function. Paradoxically, it has been suggested 
that uric acid have antioxidant activity in experimental studies 
(7). In addition, it has been reported that uric acid administra-
tion to healthy volunteers increase their serum antioxidant ca-
pacity (8). Studies have shown that the relationship between 
serum uric acid and cardiovascular risk is J-shaped with a nadir 
in the second quintile (3, 9). This may reflect the association 
between low serum uric acid and low plasma antioxidant activ-
ity (10). There are also evidences showing that hyperuricemia 
seems to induce high blood pressure, renal afferent arteriopa-
thy, a rise in glomerular hydrostatic pressure, and renal scarring 
(11). However, the relationship between the estimated glomer-
ular filtration rate (eGFR) and serum uric acid has not been stud-
ied in people with normal serum levels of uric acid. Therefore, 
we aimed to investigate the association between eGFR and uric 
acid in a general population with physiological serum levels of 
uric acid.
MATERIALS AND METHODS
Study population
We studied adults who were between 20-80 yr old and visited 
Gangnam Severance Hospital for Preventive Medicine for a med-
ical examination and health counseling. Cross-sectional surveys 
of adults listed on the electoral roll were undertaken from No-
vember 2006 to June 2007. This study is based on an analysis of 
the data from 2,170 males and 1,658 females at the time of their 
first survey. A total of 452 subjects (274 men, and 178 women) 
were excluded based on the following exclusion criteria: 14 sub-
jects reported the current use of blood uric acid-lowering agents; 
118 subjects had a history of cancer, ischemic heart disease, 
stroke, respiratory, renal, liver, or rheumatologic disease; 234 
had high levels of uric acid level (≥7 mg/dL for men and ≥6 mg/
dL for women) (12), and 86 had missing medical history, labo-
ratory, or urinalysis data. Because some individuals were exclud-
ed for multiple reasons, the total number of eligible subjects for 
the study was 3,376 (1,896 men, and 1,480 women).
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Data collection
Medical examinations were performed by trained medical staff 
according to a standardized procedure. Participants were asked 
about health-related behaviors, including cigarette smoking, 
alcohol consumption, and physical activity as well as current 
treatments for any type of disease. If subjects were receiving 
treatment, they were asked to provide the date of diagnosis of 
the disease and a list of medications being taken. Body weight 
and height were measured in light indoor clothing without shoes 
to the nearest 0.1 kg and 0.1 cm, respectively. Body mass index 
(BMI) was calculated as the ratio of weight (kg)/height (m2). 
After a 12-hr overnight fast, blood samples were obtained from 
each subject from the antecubital vein. Fasting plasma glucose, 
total cholesterol, triglyceride, HDL-cholesterol, high sensitivity- 
C reactive protein (CRP), and uric acid were measured using a 
Hitachi 7600-110 Chemistry analyzer (Hitachi, Tokyo, Japan). 
Kidney function was calculated using the Modification of Diet 
in Renal Disease 7 (MDRD7) equation: GFR (mL/min per 1.73 
m2)=170×(serum creatinine)-0.9994×(age)-0.176×(BUN)-0.170×(albu-
min)0.318×(0.762 if female) (13). 
 Urine protein was determined at each examination by a sin-
gle uric stick semi-quantitative analysis (URiSCAN Urine Strip; 
YD Diagnostics, Yong-In, Korea). Dipstick urinalysis was con-
ducted on fresh, midstream urine samples collected in the morn-
ing. The amount of urine protein was reported as absent, trace, 
1+, 2+ 3+, or 4+. The results of trace, 1+, 2+, 3+, and 4+ correspond 
to protein levels of about 10, 30, 100, 300, and 1,000 mg/dL, re-
spectively. Proteinuria was defined as grades of 1+ or above (14). 
Diabetes was defined as a self-reported history of the disease or 
a fasting plasma glucose level ≥126 mg/dL. Hypertension was 
defined as a self-reported history of the disorder, systolic blood 
pressure ≥140 mmHg, or diastolic blood pressure ≥90 mmHg. 
Statistical analysis
Clinical and chemical characteristics of the study population 
were summarized. All continuous variables are presented as 
means (SD) or medians (IQR), and the categorical variables are 
summarized as percentages in each group. Due to skewness, 
CRP was log transformed before statistical analyses. Pearson 
and Spearman rank correlation coefficients were determined 
for GFR vs age, BMI, cigarette smoking, regular exercise, systolic 
and diastolic blood pressure, plasma glucose, CRP, non HDL-
cholesterol, proteinuria, hypertestion, diabetes, and uric acid in 
men and women. To examine independent factors of GFR, mul-
tivariate linear regression analyses were performed. All analyses 
were conducted using SPSS statistical software (version 15.0). 
Table 1. Characteristics of the study population*
Men (n=1,896) Women (n=1,480)
Age (yr)   46.5 (10.2)   45.4 (10.8)
Body mass index (kg/m2) 24.6 (2.7) 22.8 (3.0)
Current smokers (%) 39.2 5.3
Regular exercise (%)† 64.6 48.7
Systolic blood pressure (mmHg) 125.8 (15.9) 119.7 (15.8)
Diastolic blood pressure (mmHg)   78.7 (10.2) 74.1 (9.9)
Fasting plasma glucose (mg/dL)   94.5 (19.6)   90.5 (18.2)
non HDL cholesterol (mg/dL) 132.7 (31.8) 123.8 (32.6)
CRP (mg/dL) 0.61 (0.34-1.26) 0.47 (0.26-1.05)
Proteinuria (1+<) (%)‡   4.6 1
Hypertension (%)§ 14.1 9.7
Diabetes (%)||   2.5 1.4
Uric Acid (mg/dL)   5.2 (1.0)   4.1 (0.8)
GFR (mL/min/1.73 m2)   91.9 (14.3)   94.8 (16.0)
*Data are expressed as means (SD), medians (IQR), or percentages; †Regular exercise 
was defined as over 30 min of aerobic exercise at least twice per week; ‡Proteinuria 
was defined as grades of 1+ or greater; §Hypertension was defined as a SBP ≥140 
mmHg, DBP ≥90 mmHg, or a history of this disorder; ||Diabetes was defined as a 
fasting plasma glucose level ≥126 mg/dL, or a history of the disorder.
CRP, high sensitivity-C reactive protein; GFR, glomerular filtration rate.
Table 2. Results of the multiple linear regression analysis to assess the relationship between GFR and clinical variables in men and women*
Variables
Men Women 
Parameter, β SE P value Parameter, β SE P value
Age (yr) -0.344 0.030 <0.001 0.062 0.042 0.136
BMI (kg/m2) 0.037 0.104 0.721 -0.105 0.140 0.453
SBP (mmHg) 0.013 0.041 0.743 -0.086 0.054 0.111
DBP (mmHg) -0.089 0.064 0.165 0.046 0.085 0.592
FPG (mg/dL) -0.044 0.015 0.003 -0.008 0.023 0.736
Non HDL cholesterol (mg/dL) -0.021 0.009 0.024 -0.027 0.013 0.036
Log CRP -0.516 0.690 0.454 -1.375 0.943 0.145
Uric acid (mg/dL) -4.998 0.298 <0.001 -6.118 0.479 <0.001
DM -5.926 1.840 0.001 -4.962 3.352 0.139
HTN 0.949 0.863 0.272 2.687 1.434 0.061
Cigarette smoking -1.927 0.596 0.001 -1.265 1.753 0.471
Proteinuria (1+<) -1.858 1.372 0.176 7.702 5.339 0.149
Regular exercise -0.170 0.614 0.782 -0.696 0.799 0.384
*Multivariate linear regression analysis included age, BMI, SBP, DBP, fasting plasma glucose, total cholesterol, HDL-cholesterol, log transformed triglycerides, log transformed 
CRP, current history of cigarette smoking, regular exercise, DM, hypertension, proteinuria, and uric acid as independent variables.
GFR, glomerular filtration rate; BMI, Body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; CRP, C reactive protein; DM, 
diabetes mellitus; HTN, hypertension; SE, standard error. 
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All statistical tests were 2-sided, and significance was determined 
at a P value <0.05.
Ethics statement
The study was approved by the Institutional Review Board of 
Gangnam Severance Hospital, Yonsei University, College of 
Medicine in Seoul, Korea (3-2008-0174). Informed consent was 
exempted by the review board. 
RESULTS
The data of 3,376 study participants are presented in Table 1. The 
average age was 46.5 yr for men, 45.4 yr for women, and the 
mean level of serum uric acid was 5.2 mg/dL for men and 4.1 
mg/dL for women. Approximately 39.2% of men and 5.3% of 
women were current smokers, while 64.6% of men and 48.7% 
of women exercised regularly. The overall prevalence of diabe-
tes was 2.5% for men and 1.4% for women. 
 In multivariate linear regression analysis, age, DM, cigarette 
smoking, fasting plasma glucose, non-HDL cholesterol, and uric 
acid were found to be independent variables that were signifi-
cantly associated with GFR in men. Non HDL-cholesterol and 
uric acid were found to be independent variables associated 
with GFR in women (Table 2). Multiple stepwise regression 
models were used to evaluate the association of GFR with uric 
acid (Tables, 3, 4). The association of GFR with uric acid was 
negative after adjusting for age, DM, cigarette smoking, fasting 
plasma glucose and now HDL-cholesterol (Table 4). 
 It has been observed an increase in uric acid of 1 mg/dL is in-
dependently association with a decrease in GFR of about 5 mL/
min/1.73 m2 in men and about 6 mL/min/1.73 m2 in women in 
Table 4.
DISCUSSION
In the present study, we found an association between increased 
uric acid levels and decreased GFR in Koreans with normal se-
rum levels of uric acid. The liver produces uric acid by degrad-
ing dietary and endogenously-synthesized purine compounds. 
Uric acid is reabsorbed and excreted by the proximal tubular 
cells. Therefore, hyperuricemia might develop when the produc-
tion of uric acid increases or the excretion of uric acid declines, 
or both (15). Several studies have shown that an increase in uric 
acid is associated with hypertension, cerebral vascular disease 
and chronic kidney disease (CKD) (2, 16, 17). Experimental an-
imal studies and in vitro studies have identified the mechanisms 
in which elevated uric acid levels might cause nephrotoxicity. 
Afferent arteriopathy, mild tubulointerstitial fibrosis, glomeru-
lar hypertrophy, and glomerulosclerosis occur in hyperuricemic 
rats (18). However, despite several epidemiological, experimen-
tal, and prospective cohort studies, it is still controversial wheth-
er hyperuricemia can be considered to be a risk factor for the 
progression of CKD. Sturm et al. (19) reported that uric acid lev-
els are not independent predictors of the progression of CKD. 
However, Iseki et al. (20) reported that a high level of serum uric 
acid was more predictive for the development of renal dysfunc-
tion than proteinuria. One of the reasons for the controversy 
over whether hyperuricemia is a risk factor for the progression 
of CKD is that uric acid may function as an antioxidant (21). Uric 
acid can chelate transition metals and can scavenge singlet oxy-
gen and superoxide radicals (22). GFR has been suggested to be 
an indicator of early stages of kidney dysfunction (23). Therefore, 
we investigated the association between GFR and uric acid in a 
population with normal serum levels of uric acid. In multivariate 
linear regression analysis, age, cigarette smoking, fasting blood 
sugar, DM, and uric acid were independently and negatively 
associated with GFR in men, but not in women. Non-HDL cho-
Table 3. Factors affecting GFR as determined by multiple stepwise regression analysis 
in men and women*
Variables
Men Women 
Parameter, 
β
SE P value
Parameter, 
β
SE P value
Age (yr) -0.334 0.028 <0.001 -0.035 0.036   0.328
Uric acid  
(mg/dL)
-5.672 0.273 <0.001 -6.528 0.439 <0.001
*A stepwise regression is allowed two variables to enter and remain; age and uric acid 
were the independent variables.
GFR, glomerular filtration rate.
Table 4. Factors affecting GFR as determined by multiple stepwise regression analysis in men and women*
Variables
Men  Women 
Parameter, β SE P value Parameter, β SE P value
Age (yr) -0.358 0.028 <0.001 0.025 0.036 0.499
FPG (mg/dL) -0.052 0.015 <0.001 -0.020 0.022 0.355
Non HDL cholesterol (mg/dL) -0.026 0.009 0.005 -0.037 0.012 0.003
Uric acid (mg/dL) -5.490 0.275 <0.001 -6.237 0.453 <0.001
DM -6.180 1.839 0.001 -4.942 3.322 0.137
Cigarette smoking -1.919 0.595 0.001 -1.137 1.741 0.541
*A stepwise regression is allowed six variables to enter and remain; the independent variables were age, fasting plasma glucose, non HDL-cholesterol, current history of 
cigarette smoking, DM, and uric acid.
GFR, glomerular filtration rate; FPG, fasting plasma glucose; DM, diabetes mellitus; SE, standard error.
Jung D-H, et al. • Association between Serum GFR and Uric Acid in Korean Adults
http://jkms.org  1769DOI: 10.3346/jkms.2010.25.12.1766
lesterol and uric acid were independently and negatively asso-
ciated with GFR in both men and women. Messerli et al. (24) 
reported that a decrease in GFR was correlated with an increase 
in uric acid in patients with hypertension. They argued this is 
because a low renal blood flow stimulates uric acid reabsorp-
tion. However, in our study, GFR was not significantly correlated 
with hypertension in either men or women. Galvan et al. report-
ed that hyperuricemia develops frequently in subjects with in-
sulin resistance, because insulin stimulates sodium and uric acid 
reabsorption in the proximal tubule (25). GFR was negatively 
associated with fasting blood sugar and DM in men, but not in 
women. The reason for this difference is unclear; however, the 
uricosuric effect of estrogen could be one possible reason for 
this difference (25). Recently, Chonchol et al. (26) reported that 
high uric acid levels are strongly associated with the risk of kid-
ney disease progression and a decrease in estimated GFR based 
on a prospective community-based cardiovascular health study 
of 4,610 participants. However, it is also possible that hyperuri-
cemia is just a bystander to kidney disease. One reason for this 
hypothesis is the fact that uric acid is excreted by the proximal 
tubular cells. When GFR decreases, both enteric excretion and 
fractional urinary excretion increase, but these processes do not 
fully compensate for the decrease in GFR, and hyperuricemia is 
induced (15). Therefore, CKD could be the cause of hyperurice-
mia. The other reason that hyperuricemia could just be a by-
stander to kidney disease is that uric acid is an antioxidant in 
the extracellular setting (22). Our study showed that an increase 
in uric acid of 1 mg/dL is independently associated with a GFR 
decrease of about 5 mL/min/1.73 m2 in men and about 6 mL/
min/1.73 m2 in women. Although it is possible that a high level 
of uric acid could simply be a result of low GFR, several studies 
have provided evidences that uric acid might actually play a role 
in the development or progression of renal disease. Kang et al. 
(5) showed that uric acid induced renal hypertrophy, glomeru-
losclerosis and interstitial fibrosis in animal study. Yen et al. (27) 
reported that serum uric acid level was associated with a decline 
in renal function in a prospective study. Siu et al. (11) reported 
that allopurinol therapy was able to significantly decrease the 
probability of kidney function deterioration in a prospective tri-
al of 54 hyperuricemic patients with CKD. Kanbay et al. (28) 
showed that treatment with allopurinol improved not only uric 
acid levels but also GFR in patients with normal renal function. 
These results suggest that uric acid might have play a pathologic 
role in kidney disease progression. Our findings are consistent 
with previous results showing a negative association between 
eGFR and the serum level of uric acid.
 This study has several limitations. First, we used eGFR to as-
sess renal function instead of directly measuring GFR. However, 
several organizations recommend the use of equations that es-
timate GFR to evaluate renal function in epidemiologic studies 
(29). Second, a dipstick can be inaccurate for detecting protein-
uria, because the number of false-positives can be increased by 
a comorbid illness in older people or by menstruation in wom-
en. However, in our study, we used this variable only as an ad-
justment variable. A third limitation was that the influence of 
hypertensive drugs as confounding variables was not examined. 
Diuretics such as thiazides increase serum uric acid by stimu-
lating uric acid reabsorption in the proximal tubule (30). Last, 
this was a cross-sectional study; therefore, it is not clear wheth-
er the observed serum levels of uric acid contribute to the de-
velopment of CKD. The potential therapeutic effects of lower-
ing uric acid levels in CKD patients should be investigated in 
future prospective studies.
 In conclusion, uric acid is independently and negatively as-
sociated with GFR in both men and women with normal serum 
levels of uric acid. This suggests that a high level of uric acid is a 
valuable predictor of a GFR decrease, and our findings have 
important clinical and public health implications.
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